Learn more

LISAPHARMA SPA

Overview
  • Total Patents
    76
About

LISAPHARMA SPA has a total of 76 patent applications. Its first patent ever was published in 1978. It filed its patents most often in Italy, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are HENGCHENG PHARMACEUTICAL CO LTD, SYDNEXIS INC and ELLIPSE PHARMACEUTICALS.

Patent filings per year

Chart showing LISAPHARMA SPAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Colombo Paolo 46
#2 Zagnoli Giorgio 40
#3 Conte Ubaldo 29
#4 Santi Patrizia 12
#5 Caramella Carla 11
#6 Padula Cristina 9
#7 Colombo Gaia 8
#8 Catellani Pier Luigi 7
#9 Conte U 7
#10 Zagnoli G 6

Latest patents

Publication Filing date Title
EP2654813A1 Sprayable pharmaceutical compositions for topical application comprising sucralfate gel
WO2010048981A1 Sprayable pharmaceutical compositions comprising sucralfate gel for treating skin or mucosa lesions
CA2574682A1 Device for transdermal delivery of active principles
AU1594402A Film for active ingredients dermal and transdermal administration
WO0006201A1 Process for the preparation of granular and porous sucralfate dry gel
AU8628998A Dermal adhesive plaster suitable for treating localized cutaneous affections
CH692837A5 A pharmaceutical composition for use in foodstuffs, dietetic or medicinal product suitable to improve the oral absorption of the polyphenols and particularly of resveratrol present in grapes and in its p
AU7533394A Antiacid pharmaceutical composition in the form of a suspension based on sucralphate gel
CN1091290A Pharmaceutical compositions containing an aminoglycosidic antibiotic, suitable for the topical administration
EP0402933A2 Use of sucralfate humid gel as vehicle for drugs having topic activity and for cosmetics
EP0286978A1 Pharmaceutical compositions in the form of stable sucralfate suspensions free of suspending agents
EP0253083A2 Topical vaginal use of lysine p-isobutylphenylpropionate in antiinflammatory treatment
CA1262733A Pharmaceutically active salt derivative of 3-hydroxy- 5-(hydroxymethyl)-2-methylisonicotinaldehyde phosphate
KR900003456B1 Process for the preparation of 4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxyphenyl)-1-butanone 3-hydroxy-5-(hydroxy-methyl)-2-methy-lisonicotinaldehyde-5-phosphate
ES8703151A1 Salt of buflomedil and pyridoxal phosphate
US4605741A Pharmaceutically active salt derivative of 3-hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde phosphate
EP0183002A1 Pharmaceutically active salt derivative of 3-hydroxy -5-(hydroxymethyl)-2-methylisonicotinaldehyde phosphate
EP0172383A2 Pharmacologically active salt derivatives of 1,2,3,6-tetrahydro-1,3-dimethyl-2,6 dioxopurine-7-acetic acid
EP0167958A2 Oral solid pharmaceutical form with sequential action for the administering of drugs with ulcerogenic side effect
BE900604A Pharmaceutical compositions with antibiotic activity.